Keywords: Busulfan; Hepatotoxicity; Antithymocyte globulin; Proinflammatory cytokines;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Allogeneic transplant; Acute lymphoblastic leukemia; Total body irradiation; Busulfan;
Keywords: Busulfan; Myeloablative; Allogeneic; Transplantation;
Keywords: Busulfan; Gamma-radiation; Infertile rooster; Recipient testis; Spermatogenesis;
Keywords: Busulfan; Pharmacokinetics; Drug monitoring; Hematopoietic stem cell transplantation;
Keywords: Testis; Germ cell; Busulfan; Pigs;
Keywords: Multiple myeloma; Allogeneic; Myeloablative; Reduced toxicity; Prospective; Fludarabine; Busulfan
Keywords: Busulfan; Platelets; Mitochondrion; Apoptosis; Platelet activation
Keywords: Busulfan; Autologous stem cell transplantation; Lymphoma
Keywords: Busulfan; Spermatogonial stem cell; Sperm morphology; Fertility; Mice;
Keywords: Late effects; Umbilical cord blood transplantation; Myeloablative conditioning; Busulfan
Keywords: Busulfan; Myeloablative; Fludarabine;
Keywords: Busulfan; Chimerism; Stem cell transplantation; Thalassemia major; VOD;
Keywords: Busulfan; Fludarabine; Therapeutic drug monitoring; Stem cell transplantation; Acute lymphoblastic leukemia
Keywords: Total body irradiation; Busulfan; Cyclophosphamide; Hepatic veno-occlusive disease; Hematopoietic stem cell transplantation
Keywords: adverse effects; anticancer; busulfan; Panax ginseng; reproductive systems
Keywords: Umbilical cord blood; Myeloablative; Busulfan
Keywords: Busulfan; Kunming mice; Spermatogonial stem cells; Testis; Transplantation
Keywords: Neuroblastoma; meta-Iodobenzylguanidine (mIBG); Alkylating agent; Busulfan
Keywords: Biodegradable polymer; Multifunctional nanoparticles; Anticancer drug delivery; Busulfan; Fluorescence imaging; Magnetic resonance imaging
Keywords: Busulfan; Fetal rat brain; Neural progenitor cell damage; Sequence;
Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation
Keywords: Acute myeloid leukemia; Stem cell transplantation; Busulfan; Treosulfan;
Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT)
Keywords: HSCT; Hematopoietic Stem Cell Transplant; HE; hemorrhagic events; TE; thrombotic events; Cy; cyclophosphamide; Bu; busulfan; VTE; Venous Thromboembolism; ACE; Advanced Cohort Explorer; PE; pulmonary embolism; DVT; Deep Vein Thrombosis; SOS; sinusoidal obs
A rapid and simple LC-MS/MS method for personalized busulfan dosing in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT)
Keywords: HSCT; hematopoietic stem cell transplantation; CSS; concentration of steady state; Busulfan; High performance liquid chromatography-mass spectrometry;
Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach
Keywords: Busulfan; Immunosuppression; Proliposomes; Quality by design; Busulfex®;
Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning
Keywords: Busulfan; Clofarabine; Fludarabine; LC-MS/MS; Standard addition;
Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400âcGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome
Keywords: Acute myeloid leukemia; Myelodysplastic syndrome; Allogeneic hematopoietic cell transplantation; Fludarabine; Busulfan; Total body irradiation;
Role of stromal derived factor-1a (SDF-1a) for spermatogenesis of busulfan-injured rats
Keywords: Stromal cell-derived factor-1 alpha; Busulfan; Infertility; Spermatogenesis;
Heat and chemical treatments in adult Cyprinus carpio (Pisces cypriniformes) rapidly produce sterile gonads
Keywords: Busulfan; Elevated water temperature; Gonad sterilisation; Fish; Common carp;
Increased Sat2 expression is associated with busulfan-induced testicular Sertoli cell injury
Keywords: Busulfan; Sat2; Sertoli cells;
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission
Keywords: Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation; Antithymocyte globulin; Busulfan; Fludarabine; HLA-matched unrelated donor; HLA-haploidentical family donor; HLA-matched sibling donor;
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation
Keywords: Busulfan; Dosing guidelines; Pharmacogenetics; Pharmacokinetics; GSTA1; Children;
Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Keywords: Stem cell transplantation; Multiple myeloma; Conditioning regimen; Busulfan; Melphalan; Bortezomib;
Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia
Keywords: Acute lymphoblastic leukemia; Allogeneic hematopoietic cell transplantation; Total body irradiation; Busulfan;
Role of recombinant human erythropoietin loading chitosan-tripolyphosphate nanoparticles in busulfan-induced genotoxicity: Analysis of DNA fragmentation via comet assay in cultured HepG2 cells
Keywords: Busulfan; rhEPO; ROS; Nanoparticles; Comet assay; Chitosan-tripolyphosphate;
LC–MS/MS method development for quantification of busulfan in human plasma and its application in pharmacokinetic study
Keywords: LC–MS/MS; Busulfan; Busulfan d8; Validation; Human Plasma
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
Keywords: Lymphoma; Allogeneic; Stem cell transplantation; Reduced-intensity conditioning; Fludarabine; Melphalan; Busulfan;
Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study
Keywords: allo-HSCT; allogeneic hematopoietic stem cell transplantation; IDA; idarubicin; AML; acute myeloid leukemia; ALL; acute lymphocytic leukemia; OS; overall survival; DFS; disease-free survival; RR; relapse rate; BU; busulfan; CY; cyclophosphamide; VP-16; et
Long-Term Outcomes after Treatment with Clofarabineâ±âFludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome
Keywords: Conditioning regimen; Clofarabine; Busulfan; Fludarabine; Allogeneic stem cell transplantation;
GuidelinePersonalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Keywords: Hematopoietic cell transplantation; Busulfan; Precision medicine; Pharmacokinetics; Therapeutic drug monitoring;
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes
Keywords: Non-Hodgkin lymphoma; Hodgkin lymphoma; Busulfan; Autologous stem cell transplantation; Stem cell transplantation; Lymphoma; Chemotherapy;
Submyeloablative conditioning with busulfan permits bone marrow-derived cell accumulation in a murine model of Alzheimer's disease
Keywords: 3Â ÃÂ Tg mice; Bone marrow-derived cells; Busulfan; Busulfex; Chimerism; Hybrid resistance;
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
Keywords: HLA-haploidentical transplantation; Post-transplant cyclophosphamide; Reduced-intensity conditioning; Busulfan
Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation
Keywords: Chronic myeloid leukemia; Busulfan; Total body irradiation
Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A
Keywords: Acute myeloid leukemia; Children; Hematopoietic stem cell transplantation; Busulfan; Total body irradiation
Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients
Keywords: Busulfan; Allogeneic; Pharmacokinetics; Dose escalation
Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning
Keywords: Busulfan; Pediatrics; Dosing; Pharmacokinetics;
The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins
Keywords: Busulfan; Glutathionylation; Drug metabolism; Redox regulation; Mass spectrometry
Combination comet/micronucleus assay validation performed by BioReliance under the JaCVAM initiative
Keywords: In vivo comet assay; JaCVAM validation study; 1,3-Dichloropropene; Ethionamide; Busulfan; In vivo micronucleus (MN) assay; Combination comet/MN assay;
Feasibility of the fludarabine busulfan 3 days and ATG 2 days reduced toxicity conditioning in 51 allogeneic hematopoietic stem cell transplantation: A single-center experience
Keywords: Reduced toxicity conditioning; ATG; Busulfan; Allogeneic stem cell transplantation; Adult; FB3;